PNVP References

  1. Therapeutic Goods (Medicines and OTG—Authorised Supply) Rules 2022. Link

  2. Chaiton, M., et al. Estimating the number of quit attempts it takes to quit smoking successfully in a longitudinal cohort of smokers. BMJ Open. 2016;6(6). DOI

  3. Borland, R., et al. How much unsuccessful quitting activity is going on among adult smokers? Data from the International Tobacco Control Four Country cohort survey: Prevalence of quitting activity among smokers. Addiction. 2012;107(3):673-682. DOI

  4. Borland, R., et al. Motivational factors predict quit attempts but not maintenance of smoking cessation: findings from the International Tobacco Control Four country project. Nicotine & Tobacco Research. 2010 Oct;12 Suppl(Suppl 1). DOI

  5. Cooper, J., et al. Australian and New Zealand Journal of Public Health. 2011;35:368–376. DOI

  6. Dono, J., et al. The Lancet Regional Health – Western Pacific. 2022;19:100342. DOI

  7. Fagerström, K. O., et al. Addictive Behaviors. 2014;39:507–511. DOI

  8. Hawkins, J., et al. Long-term smoking relapse: a study using the British Household Panel Survey. Nicotine & Tobacco Research. 2010 Dec;12(12):1228-35. DOI

  9. Coleman, S. R. M., Piper, M. E., Byron, M. J., et al. Dual Use of Combustible Cigarettes and E-cigarettes: A Narrative Review of Current Evidence. Current Addiction Reports. 2022;9:353–362. DOI

  10. Balfour, D. J. K., Benowitz, N. L., Colby, S. M., et al. Balancing Consideration of the Risks and Benefits of E-Cigarettes. American Journal of Public Health. 2021;111(8). DOI

  11. Jackson, S. E., et al. JAMA Network Open. 2024;7. DOI

  12. Stead, L. F., Perera, R., Bullen, C., et al. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews. 2012;(11). DOI

  13. Lindson, N., Chepkin, S. C., Ye, W., Fanshawe, T. R., Bullen, C., Hartmann-Boyce, J. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews. 2019. DOI

  14. Abrams, D. B., Glasser, A. M., Villanti, A. C., Pearson, J. L., Rose, S., Niaura, R. S. Managing nicotine without smoke to save lives now: Evidence for harm minimization. Preventive Medicine. 2018;117:88-97. DOI

  15. Hajek, P., Pittaccio, K., Pesola, F., Myers Smith, K., Phillips Waller, A., Przulj, D. Nicotine delivery and users’ reactions to Juul compared with cigarettes and other e-cigarette products. Addiction. 2020;115(6):1141-1148. DOI

  16. Prochaska, J. J., Vogel, E. A., Benowitz, N. Nicotine delivery and cigarette equivalents from vaping a JUULpod. Tobacco Control. 2021. DOI

  17. O’Connell, G., Pritchard, J. D., Prue, C., et al. A randomized, open-label, cross-over clinical study to evaluate the pharmacokinetic profiles of cigarettes and e-cigarettes with nicotine salt formulations in US adult smokers. Internal and Emergency Medicine. 2019;14(6):853-861. DOI

  18. Hajek, P., Phillips-Waller, A., Przulj, D., et al. A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy. New England Journal of Medicine. 2019;380(7):629-637. DOI

  19. Myers Smith, K., Phillips Waller, A., Pesola, F., et al. E-cigarettes versus nicotine replacement treatment as harm reduction interventions for smokers who find quitting difficult: randomized controlled trial. Addiction. 2021. DOI

  20. Shifman, S., Sembower, M. A., Augustson, E. M., et al. The Adult JUUL Switching and Smoking Trajectories (ADJUSST) Study: Methods and Analysis of Loss-to-Follow-up. American Journal of Health Behavior. 2021;45(3):419-442. DOI

  21. Prakash, S., Hatcher, C., Shifman, S. Prevalence of ENDS and JUUL Use, by Smoking Status, in National Samples of Young Adults and Older Adults in the U.S. American Journal of Health Behavior. 2021;45(3):402-418. DOI

  22. McNeill, A., Brose, L. S., Calder, R., Simonavicius, E., Robson, D., King’s College London. Vaping in England: An Evidence Update Including Vaping for Smoking Cessation, February 2021. Public Health England; 2021:247. Link

  23. Shifman, S., Ferguson, S. G., Rohay, J., Gitchell, J. G. Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: relationship with use and compliance. Addiction. 2008;103(8):1371-1378. DOI

  24. RACGP. Optimising Nicotine Replacement Therapy in Clinical Practice. The Royal Australian College of General Practitioners. Accessed September 22, 2021. Link

  25. Przulj, D., Hajek, P., Phillips-Waller, A. E-Cigarettes versus Nicotine-Replacement Therapy for Smoking Cessation. New England Journal of Medicine. 2019;380(20):1973-1975. DOI

  26. Shifman, S., Sembower, M. A. Dependence on e-cigarettes and cigarettes in a cross-sectional study of US adults. Addiction. 2020;115(10):1924-1931. DOI

  27. Kimber, C. F., Soar, K., Dawkins, L. E. Changes in puffing topography and subjective effects over a 2-week period in e-cigarette naïve smokers: Effects of device type and nicotine concentrations. Addictive Behaviors. 2021;118:106909.

Prescriber hub modules